arsenic trioxide has been researched along with cryptotanshinone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Liu, P; Naranmandura, H; Rehman, K; Wang, WW; Xu, S; Zhang, M; Zhang, YF | 1 |
| Lou, Z; Shen, L; Xu, G; Zhang, G | 1 |
| Huang, JB; Jiang, T; Lou, ZH; Lu, J; Lv, YL; Xu, CY; Yang, DQ; Zhang, GJ; Zhao, ZQ | 1 |
3 other study(ies) available for arsenic trioxide and cryptotanshinone
| Article | Year |
|---|---|
Anticancer activity in human multiple myeloma U266 cells: synergy between cryptotanshinone and arsenic trioxide.
Topics: Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Drug Synergism; Humans; Multiple Myeloma; Oxides; Phenanthrenes | 2013 |
Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Survival; Down-Regulation; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Oxides; Phenanthrenes; Phosphorylation; STAT3 Transcription Factor; Xenograft Model Antitumor Assays | 2017 |
Arsenic Trioxide Cooperate Cryptotanshinone Exerts Antitumor Effect by Medicating Macrophage Polarization through Glycolysis.
Topics: Animals; Antineoplastic Agents; Arsenic Trioxide; Carcinoma, Hepatocellular; Cell Differentiation; Cytokines; Drug Combinations; Drug Synergism; Drugs, Chinese Herbal; Glycolysis; Humans; Immunity, Innate; Immunomodulation; Liver Neoplasms; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Phenanthrenes; Th1 Cells | 2022 |